Adding High-Dose Chloroquine Not Advised for Severe COVID-19
High-dose versus low-dose group had higher lethality until day 13, more instances of QTc interval >500 ms
High Rate of Pulmonary Embolism Found for Patients With COVID-19
Two studies demonstrate high rate of PE; 100 percent sensitivity for PE seen for D-dimer level > 2,660 µg/L
45.4 Percent of U.S. Adults at Risk for Complications With COVID-19
These adults may be at increased risk due to existing chronic conditions including CVD, diabetes, HTN
Upward Income Mobility Tied to Worse Cardiometabolic Health
Worse outcomes on all health indicators predicted by downward mobility
Job Strain Linked to Increase in Risk for PAD Hospitalization
Estimates varied in magnitude but were consistent by sex, socioeconomic status, baseline smoking status
Social Inequality May Contribute to Poor Metabolic, Bone Health
Risk for coexisting metabolic syndrome, osteoporosis up for postmenopausal women with low social status
U.S. Surgical Residents Report Racial/Ethnic Discrimination Common
Residents reported being mistaken for someone else of the same race or as a nonphysician
Diabetes Medication Prescribing Increased 2003 to 2016
However, authors say there is little evidence that doctors are tailoring treatment for patients
Recommendations Developed for Anesthesia Use During COVID-19
Risk for postop complications lower with regional anesthesia; odds of aerosol generation up with general anesthesia
Neurologic Features Tied to ARDS in Severe COVID-19 Described
Unclear whether critical illness, medication, infection itself may cause encephalopathy, agitation, confusion
